Wednesday, 14 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 27, 2026

Kimberly-Clark Q4 Earnings Call Highlights

View original at finance.yahoo.com
Kimberly-Clark Q4 Earnings Call Highlights Kimberly-Clark logo Key Points Eighth consecutive quarter of volume‑plus‑mix gains with enterprise‑weighted share growth and a second straight year of industry‑leading productivity, which management credits for sustaining performance in a value‑focused consumer environment…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • New generation 2 Core product provides better protection and more comfort

    80% confidence
  • Company gained global diaper share in Q4 across China, Korea, Brazil, and Indonesia

    80% confidence
  • Net sales expected to be roughly 50/50 between first and second halves of 2026, with organic growth expected to accelerate in the back half

    80% confidence
  • Kenvue acquisition will advance Kimberly-Clark toward higher growth, higher-margin spaces and position it as a global health and wellness leader

    80% confidence
  • Q4 2025 weighted global category growth fell to around 0.6% compared with roughly 2% earlier in the year

    80% confidence
  • Company expects costs in 2026 to be largely flat after managing about $200 million of input costs in 2025

    80% confidence
  • Kimberly-Clark delivered its eighth consecutive quarter of solid volume-plus-mix performance in Q4 2025

    80% confidence
  • Kenvue acquisition shareholder voting through day before January 29 was well in excess of 90% in favor

    80% confidence
  • In North America, company grew diaper share by about 100 basis points in Q4 and has grown share two years in a row

    80% confidence
  • Company has pivoted portfolio toward higher growth, higher-margin personal care categories

    80% confidence
  • Promotional activity in Q4 reflected rephasing of innovation-related activation amid competitive promotional activity

    80% confidence
  • Company expects partial loss of diapers and Pull-Ups distribution in North America club channel beginning in Q1

    80% confidence
  • Consumer focus on value not expected to change soon

    80% confidence
  • Company anticipated rising pressure on consumers 2 to 2.5 years ago and focused on delivering superior propositions across every tier

    80% confidence
  • Company has been accelerating consumer-directed, science-based innovation and breakthrough marketing

    80% confidence
  • Company expects expansion in both gross and operating profit margins in 2026

    80% confidence
  • Company outlook for 2026 implies global category backdrop around plus or minus 2%

    80% confidence
  • Recent category data hovering around 2% level as year began

    80% confidence
  • Consumer pressure and focus on value expected to persist in 2026

    80% confidence
  • Company expects Kenvue closing somewhere in the back half of the year

    80% confidence
  • Regulatory process for Kenvue acquisition tracking consistent with initial expectations, international filings expected completed by early February

    80% confidence
  • Promotional activity for the year remained below category and 2019 levels

    80% confidence
  • Company is not focused on renting share through promotion, emphasizing innovation, marketing effectiveness, and productivity instead

    80% confidence
  • Company doesn't believe promotions drive incremental consumption in essential categories, but uses them to drive trial for innovation

    80% confidence
  • Huggies Snug & Dry is the softest diaper in the value tier

    80% confidence
  • Recent consumption data is more choppy month-to-month

    80% confidence
  • Company expects another year of strong productivity around 6% in 2026

    80% confidence
  • Company gained enterprise-weighted share in Q4 2025

    80% confidence
  • Shoppers are shifting across channels and looking for different pack sizes with purchase frequency being impacted

    80% confidence
  • Club channel distribution loss impact reflected in full-year outlook as headwind of around 60 basis points

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Kimberly-Clark Q4 Earnings Call Highlights — Source | Via News | ViaNews EU